Register
Medical Council of India news | Medical Education News | Doctor News | eMediNexus

Journal Updates

Balloon Sinus Ostial Dilation for Chronic Rhinosinusitis without Nasal Polyps.
eMediNexus, 05 December 2019
#Allergy and Immunology
A new study published in The Annals of Otology Rhinology and Laryngology assessed the clinical experience of balloon sinus ostial dilation BSD in chronic rhinosinusitis without ...MORE
444 Views
0 Comments
Allergic reaction from dental bonding material through nitrile gloves.
eMediNexus, 05 December 2019
#Allergy and Immunology
A new study published in the Journal of Esthetic and Restorative Dentistry examined monomer permeation of commercial dental adhesive through nitrile-based gloves and correlated f ...MORE
447 Views
0 Comments
Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
eMediNexus, 05 December 2019
#Allergy and Immunology #Rheumatology
The goal of a new study published in PLoS One was to determine the plasma levels of interleukin IL -25 and T-helper Th 2-associated cytokines IL-4 IL-5 IL-6 IL-9 IL-10 IL- ...MORE
439 Views
0 Comments
Impact of different criteria on early remission and identifying predictors of rheumatoid arthritis.
eMediNexus, 05 December 2019
#Allergy and Immunology #Rheumatology
The purpose of a new study published in Clinical Rheumatology was to assess rates of early remission to investigate the concordance across different remission definitions and to ...MORE
437 Views
0 Comments
Comorbidities in Family History May Add to Rheumatoid Arthritis Risk
eMediNexus, 05 December 2019
#Orthopedics #Pharmacist #Public Health #Rheumatology
A persons risk of rheumatoid arthritis RA was increased given a family history of rheumatologic autoimmune disease and even under certain non-autoimmune conditions a large case-control ...MORE
444 Views
0 Comments
Revisiting Chemo in EGFR-Mutant NSCLC
eMediNexus, 04 December 2019
#Hematology #Oncology #Pathology and Lab Medicine #Pharmacist #Pulmonary Medicine
Adding chemotherapy to a targeted agent doubled progression-free survival PFS for patients with advanced EGFR-mutant non-small cell lung cancer NSCLC according to two randomized trial ...MORE
461 Views
0 Comments
12345Next